Cite

HARVARD Citation

    Einsele, H. et al. (2020). The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types. Cancer. 126 (14), pp. 3192-3201. [Online]. 
  
Back to record